Publication: COVID-19-related Mortality During the First 60 Days After Kidney Transplantation.
dc.contributor.author | Pascual, Julio | |
dc.contributor.author | Melilli, Edoardo | |
dc.contributor.author | Jimenez-Martin, Carlos | |
dc.contributor.author | Gonzalez-Monte, Esther | |
dc.contributor.author | Zarraga, Sofía | |
dc.contributor.author | Gutierrez-Dalmau, Alex | |
dc.contributor.author | Lopez-Jimenez, Veronica | |
dc.contributor.author | Juega, Javier | |
dc.contributor.author | Muñoz-Cepeda, Miguel | |
dc.contributor.author | Lorenzo, Inmaculada | |
dc.contributor.author | Facundo, Carme | |
dc.contributor.author | Ruiz-Fuentes, Maria Del Carmen | |
dc.contributor.author | Mazuecos, Auxiliadora | |
dc.contributor.author | Sanchez-Alvarez, Emilio | |
dc.contributor.author | Crespo, Marta | |
dc.contributor.group | Spanish Society of Nephrology COVID-19 Group | |
dc.date.accessioned | 2023-02-09T09:36:27Z | |
dc.date.available | 2023-02-09T09:36:27Z | |
dc.date.issued | 2020-06-12 | |
dc.description.abstract | The COVID-19 pandemic prompted the decision to suspend most organ transplantation programs in affected countries, especially in Europe [1]. A recent large population-based report revealed that the cohort at highest risk of in-hospital death due to COVID-19 was the organ transplant population, with a hazard ratio of 4.27 [2]. Published experiences have been restricted to long-term stable kidney transplant (KT) recipients. Despite initial low mortality reported from China [3], further case series have shown mortality rates of up to 75% [4]. The decision to suspend KT programs has been arbitrary, as no reports of COVID-19 in the most vulnerable population, that is, patients with a very recent KT and profound immunosuppression, are available. | |
dc.description.version | Si | |
dc.identifier.citation | Pascual J, Melilli E, Jiménez-Martín C, González-Monte E, Zárraga S, Gutiérrez-Dalmau A, et al. COVID-19-related Mortality During the First 60 Days After Kidney Transplantation. Eur Urol. 2020 Oct;78(4):641-643 | |
dc.identifier.doi | 10.1016/j.eururo.2020.06.036 | |
dc.identifier.essn | 1873-7560 | |
dc.identifier.pmc | PMC7303649 | |
dc.identifier.pmid | 32624283 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303649/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.eururo.2020.06.036 | |
dc.identifier.uri | http://hdl.handle.net/10668/15880 | |
dc.issue.number | 4 | |
dc.journal.title | European urology | |
dc.journal.titleabbreviation | Eur Urol | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Puerta del Mar | |
dc.organization | Hospital Universitario Virgen de las Nieves | |
dc.organization | Hospital Universitario Regional de Málaga | |
dc.page.number | 641-643 | |
dc.provenance | Realizada la curación de contenido 20/03/2025 | |
dc.publisher | Elsevier | |
dc.pubmedtype | Letter | |
dc.pubmedtype | Multicenter Study | |
dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S0302-2838(20)30465-6 | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Transplants | |
dc.subject | Decision Making | |
dc.subject | Mortality | |
dc.subject | Immunosuppression Therapy | |
dc.subject | Organ Transplantation | |
dc.subject.decs | Informe de Investigación | |
dc.subject.decs | Trasplantes | |
dc.subject.decs | Poblaciones Vulnerables | |
dc.subject.decs | Trasplante de Órganos | |
dc.subject.decs | Terapia de Inmunosupresión | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Betacoronavirus | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Coronavirus Infections | |
dc.subject.mesh | Female | |
dc.subject.mesh | Host-Pathogen Interactions | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Immunocompromised Host | |
dc.subject.mesh | Immunosuppressive Agents | |
dc.subject.mesh | Kidney Transplantation | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Opportunistic Infections | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Pneumonia, Viral | |
dc.subject.mesh | Registries | |
dc.subject.mesh | Risk Assessment | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Spain | |
dc.subject.mesh | Time Factors | |
dc.subject.mesh | Treatment Outcome | |
dc.title | COVID-19-related Mortality During the First 60 Days After Kidney Transplantation. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 78 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1